Kirt Gardner
Analyst · Morgan Stanley. Please go ahead
Well, Magda, on your first question, first of all, that was quite a first question. Let me try to take it in the different revenue components. In terms of recurring fees, first of all, naturally, that’s going to be a function of invested assets. So the growth that we saw towards the end of the year will help us in the first quarter. And naturally, we'll also have some impact overall on the relative mix risk. So it comes down to our clients' attitudes, geopolitical attitudes. And of course, importantly, it's a continued mandate penetration. And that remains a clear focus for both Tom and Iqbal. We would still view that, compared to competitors in the U.S., for example, we’re relatively lower penetrated under contract, and we see good opportunities for increasing our penetration. Related to that as well, thematic investing is something we highlighted. We think there's significant opportunities and there’s tremendous demand around thematic investing, for example, around aging, health, genetics and the like, along with sustainability. And we're leaders in all of those areas. Now in terms of NII, clearly, if we do nothing else, we will see our NII come down just because of the headwinds that are already built into the forward rates. That’s clear. So naturally, lending becomes the most important way for us to continue to offset those headwinds. And we talked about the lending momentum we saw in the second quarter, the focus on expanding collateral classes, increasing the level of lending we’re doing across single stocks. Moving into commercial lending, we’re looking at business lending. So there’s quite a bit of activity around that lending. And that, of course, importantly, leverages the IB capability in terms of how they risk manage the book. Now finally, around transaction revenue. First of all, we’re pretty pleased with the momentum we see. We do believe, going forward, as clients are currently more active, and you saw that in our outlook statement for the first quarter, we do think structured products continues to be an opportunity in this environment, continued yield enhancement, locking in gains. We’ve combined our capital markets teams between the IB and Wealth Management, and we’re deploying those to be closer to clients. And I would mention just one other area of growth opportunity, and that’s GFO. So if you look at Slide 13, the fact that we're increasing our GFO clients to 1,500, and you see the compounded annual growth when we onboard a GFO client at 15% a year, so that is one of our highest growth opportunities for Wealth Management.